These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A drug to ease attention deficit-hyperactivity disorder. Smitherman CH MCN Am J Matern Child Nurs; 1990; 15(6):362-5. PubMed ID: 2124318 [No Abstract] [Full Text] [Related]
4. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962 [TBL] [Abstract][Full Text] [Related]
5. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730 [No Abstract] [Full Text] [Related]
7. Sequential evaluation of behavioral treatments and methylphenidate dosage for children with attention deficit hyperactivity disorder. Gulley V; Northup J; Hupp S; Spera S; LeVelle J; Ridgway A J Appl Behav Anal; 2003; 36(3):375-8. PubMed ID: 14596580 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131 [TBL] [Abstract][Full Text] [Related]
11. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related]
12. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750 [TBL] [Abstract][Full Text] [Related]
13. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289 [TBL] [Abstract][Full Text] [Related]
14. Effect of methylphenidate on time perception in children with attention-deficit/hyperactivity disorder. Baldwin RL; Chelonis JJ; Flake RA; Edwards MC; Feild CR; Meaux JB; Paule MG Exp Clin Psychopharmacol; 2004 Feb; 12(1):57-64. PubMed ID: 14769100 [TBL] [Abstract][Full Text] [Related]
15. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. Kaufmann R; Goldberg-Stern H; Shuper A J Child Neurol; 2009 Jun; 24(6):727-33. PubMed ID: 19491115 [TBL] [Abstract][Full Text] [Related]
16. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder. Bental B; Tirosh E J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348 [TBL] [Abstract][Full Text] [Related]
18. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy. Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014 [TBL] [Abstract][Full Text] [Related]
20. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial. Golubchik P; Sever J; Zalsman G; Weizman A Int Clin Psychopharmacol; 2008 Jul; 23(4):228-31. PubMed ID: 18446088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]